持续升高的呼出气一氧化氮分数与慢阻肺急性加重风险增加相关
该前瞻性研究纳入226例临床稳定的慢阻肺门诊患者,在招募时及随访6、12个月时测定FeNO,按FeNO≥20 ppb的访视次数分层。结果显示持续FeNO≥20 ppb者随访期间慢阻肺急性加重率显著更高,校正混杂因素后风险比升高,且FeNO与循环嗜酸性粒细胞无关。
要点
- 持续FeNO≥20 ppb的稳定期慢阻肺患者急性加重风险显著增加。
- FeNO持续升高者首次中重度急性加重时间更短。
- FeNO水平与循环嗜酸性粒细胞无相关性。
核心结论
- 临床稳定的慢阻肺门诊患者中,持续FeNO≥20 ppb与急性加重风险显著升高相关。
研究设计与样本
- 前瞻性研究,纳入226例临床稳定的慢阻肺门诊患者,在招募时及随访6、12个月时测定FeNO。
主要发现
- 三次访视FeNO均<20 ppb者占44.2%,仅访视1≥20 ppb者占29.6%,访视2或3≥20 ppb者占26.1%。
- 三组随访期间急性加重率分别为0.67、0.91和1.42,p<0.001。
- 校正潜在混杂变量后,访视2或3≥20 ppb组急性加重风险比1.579(95%CI 1.049-2.378),p=0.029。
- 该组首次中度和重度急性加重时间更短。
- FeNO水平与循环嗜酸性粒细胞无相关性。
关键数值与推荐
- FeNO分层阈值:≥20 ppb。
- 急性加重风险比:1.579(95%CI 1.049-2.378),p=0.029。
临床怎么用
- 对稳定期慢阻肺门诊患者,随访中持续FeNO≥20 ppb可提示急性加重高风险,或有助于风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preventing the occurrence of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is a major therapeutic goal. We hypothesise that persistently increased levels of exhaled nitric oxide (FeNO) during follow-up can identify a group of COPD patients at higher risk of AECOPD.To test this hypothesis, we measured FeNO levels (HypAir FeNO®, Medisoft; Sorinnes, Belgium) prospectively in 226 clinically stable COPD outpatients at recruitment and during follow-up (at 6 and 12 months). Patients were stratified according to the number of visits with FeNO ≥20 ppb.FeNO was <20 ppb in all three visits in 44.2% of patients, 29.6% in visit 1 and 26.1% in visit 2 or 3. These three groups suffered progressively higher AECOPD rates during follow-up (0.67, 0.91 and 1.42, respectively, p<0.001). After adjusting for potential confounding variables (log-rank test), the hazard ratio for AECOPD was higher in the latter group (1.579 (95% CI 1.049-2.378), p=0.029). Likewise, time to first moderate and severe AECOPD was shorter in these patients. Finally, there was no relationship between FeNO levels and circulating eosinophils.Persistent FeNO levels ≥20 ppb in clinically stable COPD outpatients are associated with a significantly higher risk of AECOPD.
引用
- Alcázar-Navarrete B, Ruiz Rodríguez O, Conde Baena P, et al. Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD. Eur Respir J. 2018. PMID: 29348180. doi:10.1183/13993003.01457-2017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。